Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Glycogen Storage Disease Iii. Data from NIH RePORTER, last 36 months.
Glycogen Storage Disease Iii has emerging NIH research funding with 1 grant totaling $3.3M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Glycogen Storage Disease Iii. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Epidemiology / Natural History.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for glycogen storage disease III. Trials may be industry-sponsored or funded through non-NIH sources.
6 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for glycogen storage disease III. Existing research activity suggests this may be a viable area for grant applications.
5 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for glycogen storage disease III. Existing research activity suggests this may be a viable area for grant applications.